379 related articles for article (PubMed ID: 12190122)
1. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
2. Intracameral muramyl dipeptide-induced paracellular permeability associated with decreased glutamate transporter and gamma -glutamyltranspeptidase activities.
Langford MP; Chen D; Neff AG; Redens TB; Berg ME; Ganley JP; Dass P; Welbourne TC
Exp Eye Res; 1999 May; 68(5):591-600. PubMed ID: 10328973
[TBL] [Abstract][Full Text] [Related]
3. Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells.
Chen D; Duggan C; Reden TB; Kooragayala LM; Texada DE; Langford MP
Biochemistry; 2004 Sep; 43(37):11796-801. PubMed ID: 15362864
[TBL] [Abstract][Full Text] [Related]
4. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.
Shi F; Kurzman ID; MacEwen EG
Cancer Biother; 1995; 10(4):317-25. PubMed ID: 8590897
[TBL] [Abstract][Full Text] [Related]
6. Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells.
Chen D; Texada DE; Duggan C; Liang C; Reden TB; Kooragayala LM; Langford MP
J Biol Chem; 2005 Jun; 280(23):22425-36. PubMed ID: 15817475
[TBL] [Abstract][Full Text] [Related]
7. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
[TBL] [Abstract][Full Text] [Related]
8. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
Dinarello CA; Elin RJ; Chedid L; Wolff SM
J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
[TBL] [Abstract][Full Text] [Related]
10. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
11. Bilateral acute pyogenic conjunctivitis with iritis induced by unilateral topical application of bacterial peptidoglycan muramyl dipeptide in adult rabbits.
Langford MP; Foreman BD; Srur L; Ganley JP; Redens TB
Exp Eye Res; 2013 Nov; 116():324-36. PubMed ID: 24135297
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endogenous pyrogen-induced fever by a muramyl dipeptide derivative.
Parant M; Riveau G; Parant F; Chedid L
Am J Physiol; 1984 Sep; 247(3 Pt 1):C169-74. PubMed ID: 6476105
[TBL] [Abstract][Full Text] [Related]
14. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
15. Muramyl dipeptide-induced sleep and fever: effects of ambient temperature and time of injections.
Shoham S; Krueger JM
Am J Physiol; 1988 Jul; 255(1 Pt 2):R157-65. PubMed ID: 3394839
[TBL] [Abstract][Full Text] [Related]
16. Central pyrogenic activity of muramyl dipeptide.
Riveau G; Masek K; Parant M; Chedid L
J Exp Med; 1980 Oct; 152(4):869-77. PubMed ID: 7420023
[TBL] [Abstract][Full Text] [Related]
17. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
Iribe H; Koga T
Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
Löwy I; Leclerc C; Bourgeois E; Chedid L
J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
